Acadia Healthcare (NASDAQ:ACHC) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.

Several other brokerages also recently weighed in on ACHC. Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. KeyCorp reissued a “buy” rating and set a $59.00 price target on shares of Acadia Healthcare in a research report on Friday, October 20th. Bank of America reduced their price target on shares of Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th. Deutsche Bank downgraded shares of Acadia Healthcare from a “buy” rating to a “hold” rating and reduced their price target for the company from $60.00 to $37.00 in a research report on Wednesday, October 25th. Finally, Robert W. Baird downgraded shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating and reduced their price target for the company from $55.00 to $38.00 in a research report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $45.08.

Shares of Acadia Healthcare (NASDAQ:ACHC) opened at $32.20 on Wednesday. The firm has a market cap of $2,830.00, a P/E ratio of 16.43, a P/E/G ratio of 1.20 and a beta of 0.90. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a 1 year low of $26.92 and a 1 year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). The firm had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. Acadia Healthcare’s revenue was down 2.4% on a year-over-year basis. During the same period last year, the business earned $0.58 EPS. research analysts forecast that Acadia Healthcare will post 2.23 EPS for the current fiscal year.

In related news, Director Reeve B. Waud sold 100,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 11.10% of the company’s stock.

Several institutional investors have recently modified their holdings of ACHC. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Acadia Healthcare by 11.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after acquiring an additional 270 shares during the last quarter. C M Bidwell & Associates Ltd. purchased a new position in shares of Acadia Healthcare during the 2nd quarter worth $205,000. Riverhead Capital Management LLC purchased a new position in shares of Acadia Healthcare during the 2nd quarter worth $209,000. Rathbone Brothers plc purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth $223,000. Finally, SG Americas Securities LLC purchased a new position in shares of Acadia Healthcare during the 2nd quarter worth $280,000.

COPYRIGHT VIOLATION NOTICE: This piece was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/12/27/acadia-healthcare-achc-rating-increased-to-hold-at-bidaskclub.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.